Kết quả tìm kiếm - Ralf‐Dieter Hofheinz

Tinh chỉnh kết quả
  1. 1
    HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments

    HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments Bằng Magdalena K. Scheck, Ralf‐Dieter Hofheinz, Sylvie Lorenzen

    Được phát hành 2024
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a metaanalysis

    A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a metaanalysis Bằng Janja Ocvirk, S. Heeger, Philip McCloud, Ralf‐Dieter Hofheinz

    Được phát hành 2013
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Treatment decisions in metastatic colorectal cancer – Beyond first and second line combination therapies

    Treatment decisions in metastatic colorectal cancer – Beyond first and second line combination therapies Bằng Arndt Vogel, Ralf‐Dieter Hofheinz, Stefan Kubicka, Dirk Arnold

    Được phát hành 2017
    lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models

    Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models Bằng Moying Li, Qiyun Xiao, Nachiyappan Venkatachalam, Ralf‐Dieter Hofheinz, Marlon R. Veldwijk, Carsten Herskind, Matthias Ebert, Tianzuo Zhan

    Được phát hành 2022
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    An Open-Label, Phase I Study of the Polo-like Kinase-1 Inhibitor, BI 2536, in Patients with Advanced Solid Tumors

    An Open-Label, Phase I Study of the Polo-like Kinase-1 Inhibitor, BI 2536, in Patients with Advanced Solid Tumors Bằng Ralf‐Dieter Hofheinz, Salah‐Eddin Al‐Batran, Andreas Hochhaus, Elke Jäger, Volker L. Reichardt, Holger Fritsch, Dirk Trommeshauser, Gerd Munzert

    Được phát hành 2010
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors

    Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors Bằng Ralf‐Dieter Hofheinz, G. Deplanque, Yoshito Komatsu, Yoshimitsu Kobayashi, Janja Ocvirk, Patrizia Racca, Silke Guenther, Jun Zhang, Mario E. Lacouture, Aminah Jatoi

    Được phát hành 2016
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Radiotherapy for Neoadjuvant Therapy of Rectal Cancer

    Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Radiotherapy for Neoadjuvant Therapy of Rectal Cancer Bằng Ralf‐Dieter Hofheinz, Bolko von Gerstenberg-Helldorf, Frederik Wenz, U. Gnad, Uta Kraus-Tiefenbacher, A. Müldner, Rüdiger Hehlmann, Stefan Post, Andreas Hochhaus, Frank Willeke

    Được phát hành 2005
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

    RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomi... Bằng Sylvie Lorenzen, Alexander Biederstädt, Ulrich Ronellenfitsch, Christoph Reißfelder, Stefan Mönig, Frederik Wenz, Claudia Pauligk, Martin Walker, Salah‐Eddin Al‐Batran, Bernhard Haller, Ralf‐Dieter Hofheinz

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    Pan-Histone Deacetylase Inhibitor Panobinostat Sensitizes Gastric Cancer Cells to Anthracyclines via Induction of CITED2

    Pan-Histone Deacetylase Inhibitor Panobinostat Sensitizes Gastric Cancer Cells to Anthracyclines via Induction of CITED2 Bằng Ivonne Regel, Lisa Merkl, Teresa Friedrich, Elke Burgermeister, Wolfgang Zimmermann, Henrik Einwächter, Ken Herrmann, Rupert Langer, Christoph Röcken, Ralf‐Dieter Hofheinz, Roland M. Schmid, Matthias Ebert

    Được phát hành 2012
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion

    Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion Bằng Karin Potthoff, Ralf‐Dieter Hofheinz, Jessica C. Hassel, Matthias Volkenandt, Florian Lordick, J.T. Hartmann, Meinolf Karthaus, Hanno Riess, Hans‐Peter Lipp, Axel Hauschild, Tanja Trarbach, Andreas Wollenberg

    Được phát hành 2010
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

    Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer Bằng Jan Harder, Gabriele Ihorst, Volker Heinemann, Ralf‐Dieter Hofheinz, Markus Moehler, Peter Buechler, Günter Kloeppel, Christoph Röcken, Michael Bitzer, Stefan Boeck, Esther Endlicher, A. Reinacher-Schick, Claudia Schmoor, Michael Geißler

    Được phát hành 2012
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  12. 12
    WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells

    WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells Bằng Gang Yuan, Ivonne Regel, Fan Lian, Tiaan Friedrich, Ivana Hitkova, Ralf‐Dieter Hofheinz, Philipp Ströbel, Rupert Langer, Gisela Keller, Christoph Röcken, Wolfgang Zimmermann, Roland M. Schmid, M. Ebert, Elke Burgermeister

    Được phát hành 2012
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  13. 13
    Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

    Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkolog... Bằng Peter Thuss‐Patience, Ralf‐Dieter Hofheinz, Dirk Arnold, A. Florschütz, S Daum, Albrecht Kretzschmar, Luisa Mantovani‐Löffler, Dmitry Bichev, Kirstin Breithaupt, Michael Kneba, Guido Schumacher, Matthias Glanemann, Peter Schlattmann, Peter Reichardt, B. Gahn

    Được phát hành 2012
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  14. 14
    Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

    Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the... Bằng S. Al-Batran, J. T. Hartmann, Ralf‐Dieter Hofheinz, Nils Homann, Volker Rethwisch, Stephan Probst, Jan Stoehlmacher, Michael Clemens, Rolf Mahlberg, Mary Ann Fritz, G. Seipelt, Mark Sievert, Claudia Pauligk, Akin Atmaca, Elke Jäger

    Được phát hành 2008
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  15. 15
    The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax)

    The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax) Bằng S-E. Al-Batran, Wael Hozaeel, Felix Tauchert, Ralf‐Dieter Hofheinz, Axel Hinke, C. Windemuth-Kieselbach, Andreas Hübner, Martin Burmester, Michael Koenigsmann, Jörg Wiegand, Gerrit zur Hausen, Burkhard Linsse, Rosemarie Kuhl, Claudia Pauligk

    Được phát hành 2015
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  16. 16
    Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced esophagogastric adenocarcinoma: A phase <scp>II</scp> trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group

    Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive... Bằng Ralf‐Dieter Hofheinz, S. Hegewisch-Becker, Volker Kunzmann, Peter Thuss‐Patience, Martin Fuchs, Nils Homann, Ullrich Graeven, Nadine Schulte, Kirsten Merx, Michael Pohl, Swantje Held, Ralph Keller, Andrea Tannapfel, Salah‐Eddin Al‐Batran

    Được phát hành 2021
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  17. 17
    Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

    Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the... Bằng Sylvie Lorenzen, Tibor Schuster, Rainer Porschen, S. Al-Batran, Ralf‐Dieter Hofheinz, Peter Thuss‐Patience, Markus Moehler, Patricia Grabowski, Dirk Arnold, Tim F. Greten, L. Müller, Nadine Röthling, C. Peschel, Rupert Langer, Florian Lordick

    Được phát hành 2009
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  18. 18
    HER2 testing in gastric cancer: results of a German expert meeting

    HER2 testing in gastric cancer: results of a German expert meeting Bằng Florian Lordick, Salah‐Eddin Al‐Batran, Manfred Dietel, Timo Gaiser, Ralf‐Dieter Hofheinz, Thomas Kirchner, Hans Kreipe, Sylvie Lorenzen, Markus Möhler, Alexander Quaas, Christoph Röcken, Josef Rüschoff, Andrea Tannapfel, Peter Thuss‐Patience, Gustavo Baretton

    Được phát hành 2017
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  19. 19
    A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

    A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer Bằng Vera Gorbunova, J. Thaddeus Beck, Ralf‐Dieter Hofheinz, Pilar García‐Alfonso, Marina Nechaeva, Antonio Cubillo Gracián, László Mangel, Elena Élez, Dustin A. Deming, Ramesh K. Ramanathan, Alison Hewitt Torres, Danielle Sullivan, Yan Luo, Jordan Berlin

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  20. 20
    Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

    Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study Bằng Gunnar Folprecht, Carles Pericay, Mark Saunders, Anne Thomas, Rafael López‐López, Jae Kyung Roh, V. Chistyakov, Thomas Höhler, Kim Js, Ralf‐Dieter Hofheinz, Stephen P. Ackland, Daniel Swinson, М. В. Копп, Dmitry Udovitsa, Marcia Hall, Timothy Iveson, Arndt Vogel, John Zalcberg

    Được phát hành 2016
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: